Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-017436
Filing Date
2009-03-31
Accepted
2009-03-31 11:44:33
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v144703_10k.htm 10-K 1989288
2 GRAPHIC chart.jpg GRAPHIC 63494
3 v144703_ex3x1x3.htm EX-3.1.3 7864
4 v144703_ex3x1x4.htm EX-3.1.4 9958
5 v144703_ex31-1.htm EX-31.1 24088
6 v144703_ex31-2.htm EX-31.2 23102
7 v144703_ex32-1.htm EX-32.1 11314
  Complete submission text file 0001144204-09-017436.txt   2154760
Mailing Address 173 YUGU ROAD, ZHONGTIAN DASHA 16-L, HANGZHOU F4 310007
Business Address 173 YUGU ROAD, ZHONGTIAN DASHA 16-L, HANGZHOU F4 310007 732-632-9896
CHINA BIOPHARMA, INC. (Filer) CIK: 0001190132 (see all company filings)

EIN.: 043703334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50005 | Film No.: 09716864
SIC: 2834 Pharmaceutical Preparations